,,iii #aag? ,,congress #b;d ,session ,s4 ,,res4 #haf ,,9 ,,! ,,s5ate ,,( ,,! ,,unit$ ,,/ates ,septemb] #bi1 #bjbb,mr4 ,blunt 7= himself & ,mr4 ,c>d97 submitt$ ! foll[+ resolution2 :i* 0 consid]$ & agre$ to ,,resolution ,designat+ ,septemb] #d1 #bjbb1 z ,national ,polycy/ic ,kidney ,disease ,aw>5ess ,day1 & rais+ aw>5ess & und]/&+ ( polycy/ic kidney disease4 ,:]eas designat+ ,septemb] #d1 #bjbb1 z ,national ,polycy/ic ,kidney ,disease ,aw>5ess ,day w raise public aw>5ess & und]/&+ ( polycy/ic kidney disease1 "o ( ! mo/ preval5t g5etic kidney disord]s2 ,:]eas autosomal dom9ant polycy/ic kidney disease 7,,adpkd7 is ! m common type ( polycy/ic kidney disease & affects approximately #bjj1jjj to #fjj1jjj p 9 ! ,unit$ ,/ates & an e/imat$ #ab1djj1jjj p worldwide2 ,:]eas autosomal recessive polycy/ic kidney disease 7,,arpkd7 is a r>e =m ( polycy/ic kidney disease t occurs 9 #a 9 #bj1jjj live bir?s 9 ! ,unit$ ,/ates2 ,:]eas ,national ,polycy/ic ,kidney ,disease ,aw>5ess ,day w help to fo/] an und]/&+ ( ! impact polycy/ic kidney disease has on individuals & _! families2 ,:]eas polycy/ic kidney disease is a progressive1 g5etic disord] ( ! kidneys t causes damage to ! kidneys & ! c>diovascul>1 endocr9e1 hepatic1 & ga/ro9te/9al organ sy/ems2 ,:]eas1 ?\gh polycy/ic kidney disease equally affects individuals ( all ages1 races1 e?nicities1 & sexes1 gaps 9 kidney treatm5t & c>e disproportionately affect racial & e?nic m9orities1 especially ,black & ,hispanic populations2 ,:]eas ,black & ,hispanic pati5ts ) ,,adpkd rea* kidney failure e>li] & are less likely to receive a kidney transplant comp>$ ) non-,hispanic ,:ite pati5ts2 ,:]eas1 ( ! individuals diagnos$ ) ,,adpkd1 approximately #aj p]c5t h no family hi/ory ( ! disease1 ) ! disease develop+ z a spontane\s mutation2 ,:]eas !re are v few treatm5ts & no cure = polycy/ic kidney disease1 :i* is #a ( ! #d lead+ causes ( kidney failure 9 ! ,unit$ ,/ates2 ,:]eas almo/ #ej p]c5t ( individuals ) ,,adpkd develop end-/age kidney disease by age #fj2 ,:]eas fri5ds1 lov$ ones1 sp\ses1 & c>egiv]s ( individuals ) polycy/ic kidney disease c assi/ ) ! *all5ges creat$ by polycy/ic kidney disease1 includ+ by help+ su* individuals ma9ta9 a heal?y life/yle & make regul> visits to _! heal? c>e provid]s2 ,:]eas ! sev]ity ( ! symptoms ( polycy/ic kidney disease & limit$ public aw>5ess ( ! disease may cause individuals to =ego regul> visits to _! physicians or avoid foll[+ ! heal? recomm5dations ( _! doctors1 :i* exp]ts sugge/ c\ld help prev5t fur!r complications %\ld kidney failure occur2 ,:]eas individuals :o h *ronic1 life-?reat5+ diseases l polycy/ic kidney disease may exp]i5ce depression2 ,:]eas ! ,,pkd ,f\ndation & its m ?an #ce1jjj pati5t & family advocates ar\nd ! ,unit$ ,/ates are d$icat$ to-- 7#a7 conduct+ rese>* to f9d treatm5ts & a cure = polycy/ic kidney disease2 7#b7 fo/]+ public aw>5ess & und]/&+ ( polycy/ic kidney disease2 7#c7 educat+ individuals & _! families ab\t ! disease to improve _! treatm5t & c>e2 & 7#d7 provid+ support1 includ+ by sponsor+ ! annual ,walk = ,,pkd1 to raise funds = polycy/ic kidney disease rese>*1 education1 advocacy1 & aw>5ess2 & ,:]eas1 on ,septemb] #d1 #bjbb1 ! ,,pkd ,f\ndation is p>tn]+ ) si/] organizations 9 ,canada1 ,au/ralia1 & o!r c\ntries to increase int]national aw>5ess ( polycy/ic kidney disease3 ,n[1 !re=e1 be x ,t ! ,s5ate-- 7#a7 designates ,septemb] #d1 #bjbb1 z ,national ,polycy/ic ,kidney ,disease ,aw>5ess ,day2 7#b7 supports ! goals & ideals ( ,national ,polycy/ic ,kidney ,disease ,aw>5ess ,day to raise public aw>5ess & und]/&+ ( polycy/ic kidney disease2 7#c7 recognizes ! ne$ = additional rese>* to f9d a cure = polycy/ic kidney disease2 & 7#d7 enc\rages all p 9 ! ,unit$ ,/ates & int]e/$ gr\ps to support ,national ,polycy/ic ,kidney ,aw>5ess ,day ?r\gh appropriate c]emonies & activities to promote public aw>5ess ( polycy/ic kidney disease & to fo/] an und]/&+ ( ! impact ( ! disease on individuals & _! families4